BioSpace News Archive

FOXO Technologies™ Sets Second Quarter 2023 Business Update Call for Thursday, August 10, 2023 at 3:15 p.m. CT.

Vatech, a global leader in the dental imaging market, has announced that its products will be distributed by Henry Schein, helping to expand the availability of its cutting-edge products for dental clinics in North America.

Meissa Vaccines (“Meissa”), a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, today announced positive safety and immunogenicity data for MV-012-968, Meissa’s intranasal live attenuated RSV vaccine candidate, from a clinical study in RSV-naïve (seronegative) participants between the ages of six and 36 months.

New family of patent granted by Japanese Patent Office enhances BioMark’s global intellectual property position in lung cancer detection using urine as a convenient biological sample medium.

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease

AgNovos Bioscience announced today that it has enrolled the 150th patient in the clinical study titled “Randomized Controlled Study of a Local Osteo-Enhancement Procedure (LOEP) to Prevent Secondary Hip Fractures in Osteoporotic Women Undergoing Treatment of Index Hip Fractures” (RESTORE).

Nyra Medical, an innovative medical device company developing a next generation transcatheter mitral valve repair technology, announced the appointment of Lori Chmura as Chief Executive Officer and Board Director.

Sorrento Therapeutics, Inc. announced that, in connection with its ongoing chapter 11 case, the U.S. Bankruptcy Court for the Southern District of Texas entered an order approving a $105 million “stalking horse” bid for substantially all of the Debtors’ common stock, preferred stock, and warrants in Scilex Holding Company to Oramed Pharmaceuticals, Inc..

Huntsville, Alabama-based technology company Curiteva® announces FDA 510(k) clearance to market a Navigation Instrument System to complement its Prodigy® Pedicle Screw System and SI-LUTION® Sacroiliac Joint Fusion Systems.

PENTAX Medical America Inc., a division of HOYA Group, has obtained US FDA 510(k) clearance for two of its latest innovations: the PENTAX Medical INSPIRA™, a premier 4K video processor, and the i20c video endoscope series.